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Abstract
The double-stranded (ds) RNA-activated protein kinase (PKR) plays an important role in control of viral infections and cell growth. We
have studied the role of PKR in viral infection in mice that are defective in the PKR signaling pathway. Transgenic mice were derived that
constitutively express a trans-dominant-negative kinase-defective mutant PKR under control of the -actin promoter. The trans-dominant-
negative PKR mutant expressing transgenic mice do not have a detectable phenotype, similar to observations with PKR knock-out mice.
The requirement for PKR in viral pathogenesis was studied by intracerebral infection of mice with a mouse-adapted poliovirus.
Histopathological analysis revealed diffuse encephalomyelitis with severe inflammatory lesions throughout the central nervous system
(CNS) in infected wild-type mice. In contrast, histopathological evaluation of virus-injected trans-dominant-negative PKR transgenic mice
as well as PKR knock-out mice yielded no signs of tissue damage associated with inflammatory host responses. However, the virus did
replicate in both models of PKR-deficient mice at a level equal to that observed in wild-type infected mice. Although the results indicate
a clear difference in susceptibility to poliovirus-induced encephalitis, this difference manifests clinically as a slight delay in fatal neuropathy
in trans-dominant-negative PKR transgenic and PKR knock-out animals. Our observations support the finding that viral-induced PKR
activation may play a significant role in pathogenesis by mediating the host response to viral CNS infection. They support PKR to be an
effective target to control tissue damage due to deleterious host responses to viral infection.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The interferon-induced double-stranded RNA-activated
protein kinase (PKR) was first identified as a component of
the host-defense mechanism induced by type I interferons
(interferon- and -) (Samuel, 1991). PKR is a serine/
threonine protein kinase ubiquitously expressed in mamma-
lian cells (Levin and London, 1978; Kaufman, 2000). Al-
though it has long been established that treatment with
interferon and dsRNA is cytotoxic to cell cultures in vitro
(Lengyel, 1987), it is now recognized that this antiprolif-
erative and proapoptotic response is mediated through the
PKR signaling pathway (Chong et al., 1992; Koromilas et
al., 1992; Meurs et al., 1993). The mechanism by which
PKR inhibits cell growth and promotes apoptosis in inflam-
mation is unknown. However, several signaling pathways
implicated include phosphorylation of eukaryotic transla-
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tion initiation factor 2 on the alpha subunit (eIF2) (Donze
et al., 1995; Srivastava et al., 1998), and activation of
transcription factors NFB (Kumar et al., 1994; Chu et al.,
1999), STAT1 (Ramana et al., 2000), interferon regulatory
factor 1 (IRF1) (Kumar et al., 1997), and the tumor sup-
pressor p53 (Cuddihy et al., 1999a,b). In addition, recent
observations suggest that signaling through PKR for acti-
vation of NKB does not require its protein kinase activity
(Chu et al., 1999; Bonnet et al., 2000; Ishii et al., 2001).
Given the negative role of PKR on cell growth, it was
surprising that mice deleted of the PKR gene did not have a
readily detectable phenotype (Yang et al., 1995; Abraham et
al., 1999). Two PKR-deficient mouse models were created;
one deletion was targeted to the amino-terminal dsRNA
binding domain (Yang et al., 1995) and another was tar-
geted to the carboxy-terminal kinase domain (Abraham et
al., 1999). Curiously, these mice do not form spontaneous
tumors as observed with mice harboring knock-outs in other
tumor suppressor genes such as p53 (Donehower et al.,
1992). In addition, the defect in induction of type 1 inter-
feron and activation of NFB in response to poly(I:C) in
embryonic fibroblasts from PKR-deficient mice was cor-
rected by pretreatment with interferon (Yang et al., 1995).
Therefore, it was suggested that the deletion creates a partial
Fig. 1. Derivation and characterization of PKR(K296R) transgenic mice. (A) The PKR(K296R) expression vector. The mutant K296R catalytically inactive
human mutant PKR cDNA was isolated on a HindIII-PstI restriction fragment and cloned into the SalI site of the human -actin promoter vector (pHBAPr-1)
(Gunning et al., 1987) to yield pBapPKR(K296R). The human -actin promoter is followed by 50 bp of -actin 5 UTR plus intervening sequence 1. The
SV40 polyadenylation signal and plasmid sequences are derived from pcDV1 (Okayama and Berg, 1983). ClaI digestion was used to liberate the 6.4-kb
transgene construct DNA from plasmid sequence. (B) Analysis of PKR(K296R) transgene copy number. Genomic tail DNA was isolated from F1 mice (1–15,
2–28, 3–45, 4–57, 5–3, 6–20) and digested with AccI in comparison against NIH3T3 fibroblast control DNA and NIH3T3 fibroblast DNA spiked with
pBapPKR(K296R). Genomic Southern hybridization was performed using the random primed transgene construct DNA (6.4 kb ClaI) as a probe. The F1
analyzed presented three major hybridizing bands (0.8, 2.6, and 3.0 kb) representative of multicopy head-to-tail integration of the transgene construct.
Quantitation of the hybridizing bands against the pBapPKR standards yielded an estimate of gene copy number (Table 1). (C) Expression of PKR(K296R)
mRNA in transgenic mouse tissues. Total RNA was isolated from tissues of F1 mice obtained from the six founder mice (In, intestine; Kd, kidney; Gd, gonad;
Lg, lung; Sp; spleen; Br; brain; Lr, liver; Ms, muscle; Ht, heart; Sk, sketetal muscle). Reverse transcription and PCR products were quantitated after Southern
blotting and hybridization with an internal oligonucleotide probe (see Materials and methods). Representative blots F1 3–45 and 6–20 are shown and relative
expression levels were quantitated and are summarized in Table 1. Competitive RT-PCR was performed using a constant amount of RNA (1 g) isolated
from heart tissue, but altering the ratio of transgenic:nontransgenic RNA in each reaction (see Materials and methods). (D) Analysis of PKR K296P hPKR
expression in transgenic mice and MEFs. Western blot analysis of murine heart tissues from control and transgenic mice was performed with monoclonal
anti-PKR antibody 71–10. Anti-human PKR polyclonal antibody was used for Western blot detection of PKR in extracts from MEFs. (E) Phosphorylation
of eIF2 in PKR(K296R) transgenic and wild-type MEFs. MEFs were stimulated for 16 h with 100 g/ml pIC in the presence or absence of actinomycin
D (50 ng/ml) added to culture medium. Phosphorylation of eIF2 was measured by Western blotting with antiphosphorylated Ser51 eIF2 antibody followed
by stripping and reprobing with antitotal eIF2 antibody.
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loss-of-function in PKR consistent with the potential for the
deleted allele to produce an amino-terminal truncated PKR
protein in these mice (Yang et al., 1995). Alternatively, a
redundant PKR pathway might exist in the PKR-deleted
mice. Recently, a mammalian homologue of yeast GCN2
gene (Sood et al., 2000) and an endoplasmic reticulum (ER)
localized eIF2 kinase that is activated upon ER stress were
identified (Shi et al., 1998; Harding et al., 1999). Therefore,
it is possible that another PKR-related eIF2 kinase exists
that may respond to dsRNA and provide tumor suppressor
activity in the absence of PKR. To directly test the require-
ment for PKR kinase activity and the potential existence of
additional PKR homologues, we derived mice that are de-
fective in the PKR pathway by expression of a transgene
that encodes a trans-dominant negative mutant of PKR that
is defective in kinase activity (K296R). Transgenic mice
that express this trans-dominant-negative PKR mutant will
elucidate the requirement for PKR kinase activity in PKR-
dependent responses. Whereas wild-type mice display se-
vere encephalitis upon intracerebral viral infection, these
mutant PKR transgenic mice, as well as PKR-null mice,
were protected from the encephalitis lesions.
Results
To evaluate the role of PKR in viral pathogenesis, we
used a transgenic mouse strain that constitutively expresses
the K296R mutant of human PKR under control of the
constitutive -actin promoter (Fig. 1A) (Gunning et al.,
Fig. 1 (continued)
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1987). The K296R mutation was previously demonstrated
to act in a trans-dominant negative manner to inhibit the
endogenous PKR (Chong et al., 1992). Southern blot anal-
ysis was used to quantitate that six different founder mice
had between 2 and 25 copies of transgene/genome (Fig. 1B;
Table 1). The transgene expression unit was intact in all
founders and multiple copies were found in a “head-to-tail”
tandem repeat arrangement, typical of transgene insertion.
Northern blot analysis detected a 2.1-kb human PKR
mRNA transcript in tissues from transgenic mice (data not
shown). RT-PCR detected transgene mRNA in multiple
tissues (Fig. 1C shows data for founders 3–45 and 6–20).
PKR (K296R) mRNA expression for all founders is sum-
marized in Table 1. To quantitate transgene expression
relative to the endogenous murine PKR, competitive RT-
PCR was performed. This analysis demonstrated that trans-
gene mRNA was present at levels approximately five-fold
greater than that of the endogenous PKR transcript in two
different founders (3–45, 5–3) (Fig. 1C, bottom, shows data
for founder 3–45). These mice have been under continual
observation for over 4 years and appear phenotypically
normal. Subsequent studies were performed with mice de-
rived from founder 3-45.
PKR transgene expression was monitored by Western
Table 1
Expression of PKR(K296R) in transgenic mouse tissues
Founder F1 Gene
copy
no.
PKR (K296R) mRNA
In Kd Gd Lg Sp Br Lr Ms Ht Sk
1 15 25          
2 28 3          
3a 45 5          
4 57 20          
5 3 2          ,
6 20 3          
Note. Expression of PKR(K296R) in transgenic mouse tissues. Gene copy number was determined by genomic Southern analysis (Fig. 1B). Total RNA
was isolated from F1 intestine, kidney, gonads, lung, spleen, brain, liver, muscle, heart, and skin. Relative mRNA expression levels were derived from
quantitative RT-PCR. Expression levels were highest in heart, lung, and gonadal tissue.
a All subsequent studies of the PKR transgenic mice were performed with mice derived from 3–45.
Fig. 1 (continued)
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blot analysis of heart tissue and murine embryonic fibro-
blasts (MEFs) (Fig. 1D). Human PKR was expressed at a
significant level in transgenic murine heart tissue (Fig. 1D;
lanes 2–4). Although endogenous murine PKR in MEFs
was expressed at very low levels under basal conditions,
after induction by overnight treatment with IFN (1000
u/ml), PKR was detected in both wild-type and PKR
(K296R) fibroblasts. No induced product was detected in
PKR “knock-out” fibroblasts. A considerable level of trans-
genic human PKR (K296R) protein was detected in the
transgenic MEFs. The apparent molecular weight of the
human PKR (68 kDa) is slightly higher than the murine
form (65 kDa), as expected.
To ascertain whether expression of the PKR transgene
altered the level of eIF2 phosphorylation in vivo, the
eIF2 phosphorylation status was measured in MEFs.
Western immunoblot analysis was performed with an anti-
body specific for the phosphorylated form of eIF2 (Sriv-
astava et al., 1998). The same blot was then reprobed with
an eIF2 antibody that reacts with total eIF2. The com-
parison of the intensity from these two probings indicates
the relative level of eIF2 phosphorylation. The basal level
of eIF2 phosphorylation was not altered in MEFs isolated
from PKR (K296R) transgenic mice and mice that harbor
the amino-terminal PKR deletion compared to wild-type
mice (Yang et al., 1995) (Fig. 1E). This is consistent with
findings that constitutive eIF2 phosphorylation is not
maintained by the PKR eIF2 kinase, but rather reflects the
activities of GCN2 and/or PERK (Harding et al. 2000;
Zhang et al., 2002). The level of eIF2 phosphorylation was
also measured after stimulation with dsRNA, poly(I):
poly(C). Where treatment with poly(I):poly(C) increased
eIF2 phosphorylation in the control MEFs, phosphoryla-
tion of eIF2 in the MEFs from the homozygous trans-
dominant-negative PKR mutant mice was not increased
(Fig. 1E, right). The level of eIF2 phosphorylation was
also measured after stimulation with the apoptotic stimuli of
poly(I):poly(C) in the presence of actinomycin D. Here,
phosphorylation of eIF2 was again enhanced in the control
MEFs, whereas phosphorylation was not increased in MEFs
from the heterozygous or homozygous mutant PKR mice.
Interestingly, there was a 2.5-fold increase in the level of
eIF2 phosphorylation in the MEFs harboring the
PKR(K296R) transgene when treated with interferon and
poly(I):poly(C) that was comparable to the increase in phos-
phorylation observed in wild-type MEFs under these con-
ditions (data not shown). It is likely that the interferon-
induced expression of the endogenous PKR gene can titrate
out the ability of the mutant transgene to inhibit eIF2
phosphorylation under the activating conditions of pIC
transfection.
To elucidate whether PKR might play a role in viral
encephalitis, we used a poliovirus model system for viral
encephalitis. Although poliovirus cannot infect rodents nat-
urally, a serotype 2 poliovirus strain isolated from a fatal
case of poliomyelitis in 1942 in Cairo, Egypt [PV2(MEF-
1)] has proven to express a mouse-neuropathogenic pheno-
type after intracerebral inoculation (Schlesinger et al.,
1943). The clinical and histopathological features of diffuse
encephalomyelitis in rodents following infection with po-
liovirus type 2 isolates are fundamentally different from
poliomyelitis occurring in primates (Gromeier et al., 1995).
These differences can be ascribed to the absence of the
human poliovirus receptor CD155 in rodents. CD155 me-
diates the characteristic neuropathological features of polio-
virus, restricting tropism to brain stem and spinal cord
anterior horn motor neurons in primates (Gromeier et al.,
1996). We have chosen PV2 infection as a model for ex-
perimental encephalitis because PV2 encephalomyelitis in
wild-type mice is a highly reproducible, rapidly progressive
syndrome dominated by severe and extensive inflammatory
lesions in circumscribed areas of the brain resulting in
irreversible tissue damage (Gromeier et al., 1995). Since
histopathological damage appears to be mediated mainly by
host responses to viral infection, this model presents a
unique opportunity to study the effect of PKR on inflam-
matory responses to viral CNS infection.
Homozygous PKR (K296R) transgenic mice and non-
transgenic control mice of the same genetic background
were injected with PV2. The transgenic mice developed
neurological symptoms after infection of PV2(MEF-1), but
in contrast to age-matched nontransgenic control animals,
the onset of disease was slightly delayed and progression of
symptoms was protracted (Fig. 2). Histopathological eval-
uation of brain and spinal cord tissue from both groups of
infected animals found the differences in clinical suscepti-
bility to correlate with a significant divergence in the sever-
ity and histopathological pattern of CNS lesions.
In comparison with uninfected nontransgenic mice (Fig.
3; left panels), infected nontransgenic C57Bl/6J mice (Fig.
3; middle panels) developed a diffuse encephalomyelitis
with extensive lesions throughout the cerebral hemispheres
and spinal cord similar to ICR–or Swiss–Webster mice
described earlier (Gromeier et al., 1995). Damage, although
distributed throughout the brain (Fig. 3B; frontal cortex; E,
hippocampal formation; and H, lumbosacral spinal cord),
focused on the hippocampal formations bilaterally, with
Fig. 2. Progression to terminal neurological disease was protracted in
PKR(K296R) mice. The % survival after intracerebral injection of PV2
was evaluated in C57B1/6J (open symbols) and trans-dominant-negative
PKR(K296R) (solid symbols) mice. Virus-injected mice were evaluated
daily after virus administration (day 0). All mice in the study succumbed
to PV2 infection, but progression was protracted in the transgenic mice.
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severe involvement of adjacent occipital and piriform cor-
tical areas, the basal ganglia, as well as the spinal cord.
In accordance with the histopathological characteristics
of viral encephalitis in humans, poliovirus-induced enceph-
alomyelitis in C57Bl/6J mice was dominated by extensive
microgliosis (Figs. 4C and E show characteristic lesions of
the hippocampal formation and cortical areas at higher mag-
nification). Microglial proliferation and invasion were most
evident in subependymal and periventricular areas, the hip-
pocampal formation and the basal ganglia bilaterally, as
well as the spinal cord. The extent and intensity of enceph-
alitis and its predominant feature microgliosis were equally
grave in all infected control C57Bl/6J animals studied. In
particular, bilateral severe involvement of the hippocampal
formation was universally observed in infected mice (Figs.
4A and C).
In sharp contrast, the transgenic mutant PKR (K296R)
mice did not develop significant histopathological lesions in
the areas typically affected by PV2 (Fig. 3; right panels).
The hippocampal formations, neighboring cortical areas,
and all other brain regions of infected animals appeared
relatively unaffected (Figs. 3C, F, and J). Minor signs of
microgliosis in PKR(K296R) mice indicated that, despite
the quantitative differences to PV2-induced encephalitis in
wild-type C57Bl/6J mice, the histopathological characteris-
tics of lesions were similar (Figs. 4B, D, and F). The
hallmark signs of severe microglial profileration affecting
the hippocampal formations was absent in PKR(K296R)
Fig. 3. PKR(K296R) transgenic mice are protected from PV2-induced destruction of neural tissue. After intracerebral inoculation of 1 106 PFU and clinical
symptoms had established in control or transgenic mice (see Materials and methods). All animals were sacrificed and neural tissues were processed for
histopathology. Histological sections showing the frontal cortex (A–C), the hippocampal formation (D–F), and the lumbosacral spinal cord (G–I) were
obtained and stained as described previously (Gromeier et al., 1996). Sections in the left column (A,D,G) were obtained from uninfected C57B1/6J mice;
specimens in the middle column (B,E,H) were derived from C57B1/6J mice inoculated intracerebrally with 1 106 PFU of PV2 and those in the right column
(C,F,I) originated from dominant-negative transgene PKR mice virus-injected with PV2 as in Fig. 2. A shows a horizontal section through the frontal cortex
of an uninfected C57B1/6J mouse. The same region of an infected littermate shows an area of cortical damage with destruction of neuronal components
(arrows) and small perivascular infiltrates (B). Cortical lesions within infected transgenic mice were absent (C). D shows horizontal section through the
hippocampal formation from an uninfected mouse. The hippocampal formation invariably harbored severe lesions in PV2-injected C57B1/6J mice (E).
Intense infiltration (black arrow) and cortical neurons in a zone of destruction (red arrow) are shown. F shows the hippocampal formation of an infected
transgenic mouse. G shows a transversal section through a normal cervical spinal cord. Lesions within the upper regions of the spinal cord were always present
in C57B1/6J mice injected with PV2 strains (H). The black arrow indicates a region of severe infiltration, cell death, and complete tissue destruction. Sections
from transgenic mice occasionally contained cytopathic neurons (I). Larger infiltrates were absent.
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mice (Fig. 4B) but, on close examination, minor foci of
microgliosis and neuronal cell death could be detected in
these animals as well (Figs. 4D and F).
These findings indicated a difference in the degree of
susceptibility toward poliovirus-induced encephalitis in the
trans-dominant-negative PKR expressing transgenic ani-
mals. This difference was evident as a relative resistance
toward virus-induced tissue damage. Histopathological ex-
amination revealed the overall extent of encephalitis in
trans-dominant-negative PKR expressing animals to be re-
duced by approximately 90%. The difference in suscepti-
bility to virus infection did not manifest itself as a distinct
entity histopathologically or clinically (apart from slightly
protracted progression), since all transgenic animals did
develop fatal CNS disease (Fig. 2).
These observations prompted us to study PV2(MEF-1)
Fig. 4. Microscopic detail of hippocampal lesions in PV2-injected C57B1/6J (A, C, E) and PKR(K296R) mice (B, D, F). (A, B) Overview of the hippocampal
formation; 12. Red and blue rectangles indicate the location of hippocampal and cortical regions shown at higher magnification, respectively. (C, D)
Extensive microgliosis affecting the hippocampal formation (arrowheads) in wild-type animals was absent in PKR(K296R) mice. (E, F) Detail of cortical
regions adjacent to the hippocampal formation is shown. Microglial proliferation extended cortically in wild-type mice (E, arrowhead). Occasionally,
minuscule lesions could be detected in PKR(K296R) mice (F, arrowhead).
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infection in the amino-terminal PKR knock-out mouse
(Yang et al., 1995). To this end, the spinal cords of PV2-
infected C57Bl/6J, and PKR/ mice were analyzed his-
topathologically (Fig. 5). Since the spinal cord harbored the
most severe virus-induced lesions in PV2-injected mice (see
Fig. 3), we focused our analysis on this compartment of the
central nervous system (CNS). In accordance with previous
observations, compared to uninfected animals (Figs. 5A and
D), there was extensive damage to the spinal cord upon PV2
infection (Figs. 5B and E). As previously described, the
lesions were characterized by extensive microgliosis,
perivasular microglial and macrophage invasion, and neu-
ronophagia (Figs. 5B and E).
In contrast, PKR/ mice were not free of virally in-
duced damage but demonstrated a consistently much more
benign pattern of lesions (Figs. 5C and F). In this study, we
also compared poliovirus replication kinetics with tissue
damage to the brain and spinal cord. After inoculation with
viral titers exceeding the LD100 100-fold, poliovirus repli-
cation was observed in the PKR/ brain and spinal cord at
levels comparable to those seen in wild-type mice (Fig. 6).
Discussion
Animal viruses and their hosts have coevolved complex
interrelationships to permit virus reproduction without de-
struction of the host organism (Shen and Shenk, 1995;
Kaufman, 1999). The interferon-induced cellular antiviral
response is the first line of defense against viral infection
within the infected cell. Upon viral infection, the expression
of interferon is induced at the transcriptional level. The
interferon is secreted to protect adjacent cells from second-
ary infection, thereby limiting viral spread. The double-
stranded (ds)RNA-activated protein kinase is the most well-
characterized interferon-induced gene product that mediates
Fig. 5. PKR/ mice are protected from poliovirus PV2-induced spinal cord destruction. PKR/ mice and control mice were injected intracerebrally with
1  108 PFU of PV2. After 4.5 days, all animals were sacrificed and their spinal cords were processed for histopathology. In infected controls, spinal cord
destruction was severe and infiltration was extensive in the meninges and around spinal blood vessels (B, E). Uninfected controls are shown for comparison
(A, D). In contrast, the PKR/ animals appeared either normal (C, F) or contained minor infiltrative lesions. Arrowheads point to neurons in the anterior
horn to show there are signs of neuronal damage also in the PKR knock-out mice. Cervical (A–C) and lumbar (D–F) sections of the spinal cord are shown.
Fig. 6. PV2(MEF-1) replication in PKR/ and PKR/ mice. Brain and
spinal cord tissues were obtained from PKR/ or wild-type mice at
different stages after intracerebral administration of PV2. Tissues were
homogenized and the viral titer of the homogenate was determined in a
plaque assay. Initial viral recovery from brain tissue is high due to the
intracerebral route of administration. The variability at time 0 is due to
differences in viral spread and recovery and is typical of these experiments.
Replication of PV2(MEF-1) in wild-type mouse brain (), spinal cord (E);
and PKR/ mouse brain (), spinal cord (F).
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the antiviral actions of type I interferons. However, the
mechanism(s) of protection provided by the PKR response
to the host upon viral infection is unclear and has only
recently been studied. It was surprising that initial studies
demonstrated deletion of PKR had little effect upon infec-
tion with EMCV and vaccinia virus (Yang et al., 1995;
Abraham et al., 1999; Stojdl et al., 2000). Amino-terminal-
deleted PKR-null mice injected with EMCV (1000 plaque-
forming units (PFU) iv) did not show decreased survival in
the absence of interferon- and only a slight effect upon
pretreatment with interferon- or poly(IC) (Yang et al.,
1995). Similarly, infection of carboxy-terminal-deleted
PKR-null mice with EMCV (100 PFU iv) showed only a
small difference in survival (Stojdl et al., 2000). Recently, it
was demonstrated that PKR is required for mice to survive
infection with either VSV or influenza virus and to mount a
response to interferon-/ (Stojdl et al., 2000; Balachand-
ran et al. 2000). In addition, MEFs from PKR-null mice
show increased replication of HSV-1 (Khabar et al., 2000).
Therefore, the cellular resistance to VSV, influenza virus,
and HSV-1 relies on a functional PKR pathway. Based on
these studies, we expected that deficiency in the PKR path-
way may sensitize the host to viral infection because of the
inability to mount an interferon protective response. How-
ever, it was surprising that PKR deficiency in both murine
trans-dominant-negative PKR transgene and PKR knock-
out genetic models provided protection of host tissue dam-
age from viral-induced encephalitis.
Our results demonstrate that the PKR pathway may pro-
vide an essential role in the inflammatory response to viral
infection in vivo. Although there are limitations from draw-
ing conclusions from transgenic mice as well as from the
PKR knock-out mice, we believe it is significant that both
models display similar histopathological evidence for re-
duced inflammation in an encephalitis model based on po-
liovirus infection. These results strongly implicate a role for
PKR functional activity in encephalitis as a result of the host
response to poliovirus infection, although the clinical out-
come was for the most part unchanged. The clinical out-
come was probably expected for the acute, very rapidly
progressive viral CNS infection studied here. In the enceph-
alitis model used, the clinical symptoms produced by the
host response to infection are overshadowed by the detri-
mental effect of rapid virus replication on the host CNS.
Changes in the clinical outcome of infection due to repres-
sion of the PKR response might be more obvious in slowly
progressive viral encephalitides. Inflammatory host re-
sponses (e.g., those mediated by PKR) play a more pro-
nounced role in the progression of clinically overt disease
where the impact of viral-induced neuronal cell death and
consequent loss of critical neurological function is less
acute.
Presently, there are four known downstream effectors
that may mediate PKR-induced proinflammatory responses
and apoptosis; eIF2, NFB, STAT1, and p53 (for review,
see Kaufman 1999). Given the role of NFB in the proin-
flammatory response (Rossi et al., 2000), it is tempting to
suggest that PKR mediates encephalitis in this model
through NFB. PKR interaction with IB kinase (IKK)
subunit  signals activation of NFB, although this re-
sponse does not require the dsRNA binding activity or PKR
kinase activity of PKR (Chu et al., 1999; Bonnet et al.,
2000; Ishii et al., 2001). These results demonstrate the
protein kinase activity of PKR is not required for NFB
signaling. Since mice that express the trans-dominant-neg-
ative kinase-mutant PKR displayed a defective inflamma-
tory response to poliovirus infection, it would appear un-
likely that the PKR-dependent inflammatory response to
viral infection in this model is mediated through NFB.
Previous studies demonstrated that poliovirus infection ac-
tivates PKR to induce eIF2 phosphorylation (Black et al.,
1989). Future experiments should identify whether eIF2
phosphorylation or another PKR target is important to me-
diate inflammation and disease symptoms.
To date, studies indicate that the status of PKR activation
in the cell may have variable consequences that depend on
the virus species and the host. In some instances, PKR
activation will elicit early apoptosis, thereby limiting viral
spread (Yeung et al., 1999; Bilgin et al., 2003). Viruses that
have mechanisms to counteract PKR activation may estab-
lish persistent or latent infections that will eventually be
detrimental to the host (Gale and Katze, 1998). Alterna-
tively, infection by some viruses, such as poliovirus studied
here, may be aggravated by viral-induced PKR-mediated
encephalitis. Although our experimental model of viral en-
cephalitis-induced inflammation supports a critical role for
PKR, it is also possible that PKR may contribute to other
physiological inflammatory responses. In this regard, it is
interesting to note that PKR-mediated eIF2 phosphoryla-
tion is associated with neuronal degeneration in Alzhei-
mer’s disease (Chang et al., 2002) and some aspects of this
disease may reflect an abnormal inflammatory response.
The ability to target and inactivate the PKR pathway may
provide an attractive therapeutic strategy to interfere with
harmful inflammatory responses to viral infections.
Materials and methods
Generation PKR(K296R) transgenic mice
The plasmid pBS-8.4 that contains wild-type human
PKR cDNA was kindly provided by Dr. B.R.G. Williams
(The Cleveland Clinic, OH) (Meurs et al., 1990). An XbaI-
SalI fragment subcloned for site-directed oligonucleotide-
mediated mutagenesis was performed by the heteroduplex
procedure to introduce the K296R mutation. The transgene
construct plasmid was generated by cloning the HindIII-PstI
PKR(K296R) cDNA into the SalI site of the human consti-
tutive -actin promoter (Bap) vector pHBAPr-1 (Gunning
et al., 1987) (Fig. 1A).
The transgenic construct DNA (6.4-kb ClaI) was isolated
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from plasmid sequences and oocyte (C57Bl/6J  SJL/J)
injections and implantations were performed in conjunction
with the University of Massachusetts at Worcester Trans-
genic Core Mouse Facility. Genomic tail DNA was pre-
pared from over 100 progeny and analyzed by PCR for
presence of the transgene. Six independent founders were
identified by PCR and confirmed by Southern blot analysis.
Founders were crossed with C57BL/6J to yield F1, which
was analyzed similarly (Fig. 1B, Table 1). Copy numbers
were estimated assuming one gene copy of a 5- to 10-kb
sequence per diploid murine genome is 1/106. Homozygotes
were selected by quantitative dot blot analysis of genomic
tail DNA using SV40 poly(A) and -actin probes. Trans-
genic mice used in these studies were derived from F1 3-45.
Expression of the transgene was evaluated in various
tissues of F1 mice from each of six founders using reverse
transcription (Perkin–Elmer, random hexamer priming) and
PCR amplification using a 5 primer from the 5UTR of the
human albumin promoter (bp 31–50) and a 3 primer from
the hPKR cDNA (bp 454–477) (3 Primer) to generate a
383-bp fragment. A portion of the human 5UTR was not
included in the transgene construct. PCR products were
analyzed by agarose gel electrophoresis, Southern blot anal-
ysis, and hybridization against an internal oligonucleo-
tide spanning the initiation codon (gaaatggctg gtgatc). Den-
sitometry scanning of film exposures was used to quantitate
and normalize expression as summarized in Table 1. An
internal control sample of mRNA isolated from
PKR(K296R)-transfected NIH3T3 cells was used to com-
pare relative expression between founders (Fig. 1C). In
quantifying expression by densitometry, the band intensities
were normalized to the internal control. Total RNA isolated
from heart tissue was used for competitive reverse transcrip-
tion and PCR using primers that react with both human and
murine PKR mRNA but yield different sized products (Fig.
1C, Table 1). When the amount of total RNA in the reaction
is held constant (1 g), the level of transgene transcript
relative to the endogenous PKR mRNA determines which
template is preferred for amplification. When the amplifi-
cation from each template is equal, the ratio of nontrans-
genic mRNA/transgenic mRNA indicates the fold overex-
pression of the transgenic mRNA.
PKR knock-out mice
PKR knockout mice were kindly provided by Dr. B.R.G.
Williams (The Cleveland Clinic, Cleveland, OH) (Yang et
al., 1995). The mouse PKR gene is disrupted by a BalI-PstI
restriction fragment deletion removing 2 kb including parts
of exons 2 and 3 and intron 2 (deleting 17 nucleotides of
noncoding region and the coding sequence for the first 79
amino acids). The deleted region is replaced by PGKNEO
insertion in the antisense orientation followed by untrans-
lated mouse sequence (UMS).
Preparation and analysis of mouse embryo fibroblasts
Mouse embryonic fibroblasts were isolated at E14.5 us-
ing standard procedures with culture in high-glucose
DMEM supplemented with 10% fetal calf serum (Hogan et
al., 1994). PKR monoclonal antibody 71-10 was kindly
provided by Dr. Ara Hovanessian. Western analysis of heart
tissues was performed using a 1:250 dilution of monoclonal
antibody with alkaline phosphatase labeled secondary for
detection. Anti-human PKR polyclonal antibody was kindly
provided by Dr. Brian Williams (Cleveland Clinic, Cleve-
land, OH). Western analysis of MEF extracts was per-
formed using a 1:500 dilution of primary antibody followed
by HRP-labeled secondary incubation and ECL detection.
eIF2 phosphorylated at Ser51 was detected using affinity-
purified antibody from Cell Signaling Tech. Inc. Total
eIF2 was detected as previously described (Srivastava et
al., 1998).
Poliovirus infection
The PKR-null mice were derived from a background of
C57Bl/6J  SV129ev. The dominant-negative PKR mice
were derived from a background of C57Bl/6J  SJL. Both
lines were back-crossed one time into C57Bl/6J. Therefore,
both the PKR-null and dominant-negative PKR mice have a
substantial contribution of C57Bl/6J in their background.
Therefore, wild-type C57Bl/6J mice were used as controls.
Since PV2 infection elicits a highly reproducible response
in inbred (C57Bl/6J; BALBc; Gromeier et al., unpublished
observations) as well as outbred mice (ICR; Swiss–Web-
ster; Gromeier et al., 1995), the differences in genetic back-
ground in our experiments are unlikely to account for the
differences observed. Homozygous PKR(K296R) trans-
genic mice (from generation F3 of founder line 3-45),
PKR/ knock-out mice, and C57Bl/6J controls were
treated with intracerebral inoculation of 1 106 or 108 PFU
PV2(MEF-1) (Figs. 2–4, 5, and 6, respectively). For the
histopathological analysis of CNS tissues, animals were
sacrificed at a preterminal stage. A preterminal stage of
severe neurological dysfunction was defined as paraplegia
with involvement of the upper extremities, and/or extrapy-
ramidal signs and respiratory strain. Because of the slightly
delayed progression of clinical disease in trans-dominant-
negative PKR mutant and PKR-null mice, these animals
were sacrificed for histopathological analysis 24–32 h later
than their wild-type peers. At the time of sacrifice, all
animals displayed a preterminal stage of severe neurological
dysfunction. Thus, the histological comparison of infected
PKR mutant or null mice and infected control mice reflects
the brain pathology at a time when clinical symptoms are
severe and comparable. Neural tissues were processed for
histopathological analysis according to standard protocols.
All tissues were embedded in paraffin, cut at a thickness of
10 m, and stained with luxol fast blue/PAS/hematoxylin.
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Analysis of viral replication
To measure viral titers in neural tissues of mice virus-
injected with PV2, brain and spinal cord samples were
dissected and suspended in phosphate-buffered saline
(PBS). Samples were then weighed and dounce homoge-
nized. The tissue homogenate was subjected to a plaque
assay following standard procedures and the amount of
plaque forming units per milligram of tissue was deter-
mined.
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